These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 31281864)

  • 41. Comparison of outcomes in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia who are treated with β-lactam vs vancomycin empiric therapy: a retrospective cohort study.
    Wong D; Wong T; Romney M; Leung V
    BMC Infect Dis; 2016 May; 16():224. PubMed ID: 27215201
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antistaphylococcal Penicillin vs Cefazolin for the Treatment of Methicillin-Susceptible
    Corsini Campioli C; Go JR; Abu Saleh O; Challener D; Yetmar Z; Osmon DR
    Open Forum Infect Dis; 2021 Mar; 8(3):ofab071. PubMed ID: 33738321
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Cefazolin Inoculum Effect Is Associated With Increased Mortality in Methicillin-Susceptible
    Miller WR; Seas C; Carvajal LP; Diaz L; Echeverri AM; Ferro C; Rios R; Porras P; Luna C; Gotuzzo E; Munita JM; Nannini E; Carcamo C; Reyes J; Arias CA
    Open Forum Infect Dis; 2018 Jun; 5(6):ofy123. PubMed ID: 29977970
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Cost-effectiveness of Cefazolin Compared With Antistaphylococcal Penicillins for the Treatment of Methicillin-Sensitive
    Pliakos EE; Ziakas PD; Mylonakis E
    Open Forum Infect Dis; 2021 Nov; 8(11):ofab476. PubMed ID: 34746331
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nationwide Organism Susceptibility Patterns to Common Preoperative Prophylactic Antibiotics: What Are We Covering?
    Nodzo SR; Boyle KK; Frisch NB
    J Arthroplasty; 2019 Jul; 34(7S):S302-S306. PubMed ID: 30745218
    [TBL] [Abstract][Full Text] [Related]  

  • 46. β-Lactam Therapy for Methicillin-Susceptible Staphylococcus aureus Bacteremia: A Comparative Review of Cefazolin versus Antistaphylococcal Penicillins.
    Li J; Echevarria KL; Traugott KA
    Pharmacotherapy; 2017 Mar; 37(3):346-360. PubMed ID: 28035690
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative effectiveness of β-lactam versus vancomycin empiric therapy in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia.
    Wong D; Wong T; Romney M; Leung V
    Ann Clin Microbiol Antimicrob; 2016 Apr; 15():27. PubMed ID: 27112143
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative effectiveness of cefazolin versus cloxacillin as definitive antibiotic therapy for MSSA bacteraemia: results from a large multicentre cohort study.
    Bai AD; Showler A; Burry L; Steinberg M; Ricciuto DR; Fernandes T; Chiu A; Raybardhan S; Science M; Fernando E; Tomlinson G; Bell CM; Morris AM
    J Antimicrob Chemother; 2015 May; 70(5):1539-46. PubMed ID: 25614044
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A large retrospective cohort study of cefazolin compared with flucloxacillin for methicillin-susceptible Staphylococcus aureus bacteraemia.
    Davis JS; Turnidge J; Tong S
    Int J Antimicrob Agents; 2018 Aug; 52(2):297-300. PubMed ID: 29499317
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of prior healthcare-associated exposure on clinical and molecular characterization of methicillin-susceptible Staphylococcus aureus bacteremia: results from a retrospective cohort study.
    Chen PY; Chuang YC; Wang JT; Chang SC
    Medicine (Baltimore); 2015 Feb; 94(5):e474. PubMed ID: 25654386
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cephalotin Versus Dicloxacillin for the Treatment of Methicillin-Susceptible
    Quiñonez-Flores A; Martinez-Guerra BA; Román-Montes CM; Tamez-Torres KM; González-Lara MF; Ponce-de-León A; Rajme-López S
    Antibiotics (Basel); 2024 Feb; 13(2):. PubMed ID: 38391562
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Empirical use of β-lactam/β-lactamase inhibitor combinations does not increase mortality compared with cloxacillin and cefazolin in methicillin-susceptible Staphylococcus aureus bacteraemia: a propensity-weighted cohort study.
    Willekens R; Puig-Asensio M; Suanzes P; Fernández-Hidalgo N; Larrosa MN; González-López JJ; Rodríguez-Pardo D; Pigrau C; Almirante B
    J Antimicrob Chemother; 2022 Jul; 77(8):2288-2295. PubMed ID: 35552420
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Comparison of Cefazolin Versus Ceftriaxone for the Treatment of Methicillin-Susceptible
    Carr DR; Stiefel U; Bonomo RA; Burant CJ; Sims SV
    Open Forum Infect Dis; 2018 May; 5(5):ofy089. PubMed ID: 30568987
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of vancomycin versus nafcillin in enhancing killing of methicillin-susceptible Staphylococcus aureus causing bacteremia by human cathelicidin LL-37.
    Le J; Dam Q; Schweizer M; Thienphrapa W; Nizet V; Sakoulas G
    Eur J Clin Microbiol Infect Dis; 2016 Sep; 35(9):1441-7. PubMed ID: 27234592
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Systematic Review and Meta-analysis of the Safety of Antistaphylococcal Penicillins Compared to Cefazolin.
    Eljaaly K; Alshehri S; Erstad BL
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29437617
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of Cefazolin Shortage on Clinical Outcomes of Adult Patients with Bacteremia Caused by Methicillin-Susceptible
    Uda A; Onuma K; Shigemura K; Kitagawa K; Yan Y; Osawa K; Yano I; Miyara T
    Antibiotics (Basel); 2021 Oct; 10(10):. PubMed ID: 34680827
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical implications of cefazolin inoculum effect and β-lactamase type on methicillin-susceptible Staphylococcus aureus bacteremia.
    Lee S; Kwon KT; Kim HI; Chang HH; Lee JM; Choe PG; Park WB; Kim NJ; Oh MD; Song DY; Kim SW
    Microb Drug Resist; 2014 Dec; 20(6):568-74. PubMed ID: 25000230
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Potent Activity of Ertapenem Plus Cefazolin Within Staphylococcal Biofilms: A Contributing Factor in the Treatment of Methicillin-Susceptible
    Gilbertie J; Ulloa ER; Daiker JC; Nguyen K; Smelter D; Rose W; Geriak M; Schnabel LV; Nizet V; Sakoulas G
    Open Forum Infect Dis; 2022 May; 9(5):ofac159. PubMed ID: 35493130
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of β-Lactam and Daptomycin Combination Therapy on Clinical Outcomes in Methicillin-susceptible Staphylococcus aureus Bacteremia: A Propensity Score-matched Analysis.
    Grillo S; Cuervo G; Carratalà J; Grau I; Pallarès N; Tebé C; Guillem Tió L; Murillo O; Ardanuy C; Domínguez MA; Shaw E; Gudiol C; Pujol M
    Clin Infect Dis; 2019 Oct; 69(9):1480-1488. PubMed ID: 30615122
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical Outcomes with Penicillin Versus Alternative β-Lactams in the Treatment of Penicillin-Susceptible Staphylococcus aureus Bacteremia.
    Shah MD; Wardlow LC; Stevenson KB; Coe KE; Reed EE
    Pharmacotherapy; 2018 Jul; 38(7):769-775. PubMed ID: 29800490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.